← SynDRA
S-18986
SynDRA canonical compound SYN1962945 — structure-anchored drug synonym record
| Clinical phase | Phase 2 |
|---|
| Primary target(s) | GRIA1 | GRIA2 | GRIA3 | GRIA4 |
|---|
| Mechanism of action | glutamate receptor modulator |
|---|
All known targets
Mechanisms of action (all sources)
- glutamate receptor modulator
Cross-references
Synonyms
- S 18986
- UNII-IA262432Y9
- S18986
- IA262432Y9
- MNTIJYGEITVWHU-SNVBAGLBSA-N
- AC1LCV4Z
- S18986-1
- SCHEMBL6622911
- S 18986-1
- GTPL4304
- CHEMBL320642
- EX-A818
- MolPort-023-276-986
- (3aS)-2,3,3a,4-tetrahydro-1H-pyrrolo[2,1-c][1,2,4]benzothiadiazine 5,5-dioxide
- ZINC3827020
- AKOS024457867
- (S)-2,3-dihydro-(3,4)cyclopentano-1,2,4-benzothiadiazine-1,1-dioxide
- B5493
- (3aS)-5,5Dioxo-2,3,3a,4-tetrahydro-1H-pyrrolo[2,1-c][1,2,4]benzothiadiazine
Look up S-18986 in the interactive SynDRA portal →